Increases in tissue levels of ubiquinone in association with peroxisome proliferation

https://doi.org/10.1016/0009-2797(95)03670-9Get rights and content

Abstract

Rats were treated with various peroxisome proliferators and concomitant changes in ubiquinone levels were monitored. In addition to clofibrate and di(2-ethylhexyl)phthalate, acetylsalicylic acid, 2-ethylhexanoic acid, thyroxine and dehydroepiandrosterone were used as proliferators. Administration of these compounds increased the contents of ubiquinone in liver and, to some extent, in kidney and muscle. No change in corresponding values for heart or brain were observed. The treatments did not influence cholesterol levels, but increased the amounts of dolichol in the liver to various extents. Treatment of rats with the catalase inhibitor aminotriazole increased the ubiquinone levels in kidney, heart and muscle but not in liver. Comparison of peroxisomal fatty acid β-oxidation with ubiquinone amounts in liver homogenates after treatment with a number of peroxisome proliferators demonstrated a direct correlation between these two parameters. Subcellular fractionation of liver after peroxisome proliferation revealed that the ubiquinone level was increased in mitochondria and lysosomes which are the main compartments for this lipid, but an increase was also observed in both peroxisomes and microsomes. The increase in hepatic ubiquinone after treatment with various types of proliferators was related to the decrease in blood cholesterol level. These results show that the volume of the peroxisomal compartment and the ubiquinone content in animal tissues are interrelated.

References (33)

  • J. Yamada et al.

    Characteristics of dehydroepian-drosterone as a peroxisome proliferator

    Biochim. Biophys. Acta

    (1991)
  • V. Kagan et al.

    Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling

    Biochem. Biophys. Res. Commun.

    (1990)
  • M. Andersson et al.

    Modulations in hepatic branch-point enzymes involved in isoprenoid biosynthesis upon dietary and drug treatments of rats

    Biochim. Biophys. Acta

    (1994)
  • E.L. Appelkvist et al.

    Biosynthesis of dolichol by rat liver peroxisomes

    Eur. J. Biochem.

    (1989)
  • E.L. Appelkvist

    In vitro labeling of peroxisomal cholesterol with radioactive precursors

    Biosci. Rep.

    (1987)
  • S.K. Krisans

    The role of peroxisomes in cholesterol metabolism

    Am. J. Respir. Cell Mol. Biol.

    (1992)
  • Cited by (31)

    • Effect of ubiquinone-10 on the stability of biomimetic membranes of relevance for the inner mitochondrial membrane

      2018, Biochimica et Biophysica Acta - Biomembranes
      Citation Excerpt :

      In the present study we have investigated the effect of ubiquinone on the lipid packing and barrier properties of membranes with a lipid composition resembling that of the inner mitochondrial membrane (IMM). A relevant feature of the IMM, which typically contains Q10 in comparably large proportions (0.5–2 mol%, related to the lipid content [23,24]), is the high content (~49 mol%) of phosphoethanolamine (PE) lipids, as well as the presence of substantial proportions (~6 mol%) of cardiolipin (CL) [25]. It is plausible that the presence of these lipids could have an important influence on the Q10-membrane interactions.

    • Ubiquinone-10 alters mechanical properties and increases stability of phospholipid membranes

      2015, Biochimica et Biophysica Acta - Biomembranes
      Citation Excerpt :

      It can be speculated that this function of Q10 would be of particular importance in the cholesterol-poor mitochondrial membranes. It is in this context interesting to note that the Q10 content in mitochondrial membranes is about 0.5–2 mol% with respect to the lipid content [67,68] and thus close to the content in the liposomes investigated in the present study. It needs to be considered, however, that ~ 20 mol% of the total lipid-associated phosphorous in the mitochondrial membranes is contributed by cardiolipins [69], which are structurally substantially different from the phosphocholines employed in the current study.

    • Increased muscle coenzyme Q10 in riboflavin responsive MADD with ETFDH gene mutations due to secondary mitochondrial proliferation

      2013, Molecular Genetics and Metabolism
      Citation Excerpt :

      But given the facts that the protein expression of mitochondrial marker, citrate synthase, was elevated and mtDNA copy number in muscle was increased, there must be mitochondrial proliferation in these MADD patients. Since CoQ10 is synthesized in the inner membrane of mitochondria and is mainly distributed in mitochondria [13], the proliferation of mitochondria should be considered as a possible cause of increased CoQ10 levels. Citrate synthase, that catalyzes the first and rate-limiting step of the Krebs cycle, is commonly used as a quantitative marker of intact mitochondrial mass.

    • Metabolism and function of coenzyme Q

      2004, Biochimica et Biophysica Acta - Biomembranes
      Citation Excerpt :

      In humans there is also an induction of some peroxisomal enzymes but no increase in the number of peroxisomes [250]. When rodents are treated with peroxisomal inducers, CoQ amount increases in various organs [251,252]. Among the most effective inducers in rat is the plasticizer di(ethylhexyl)phthalate (DEHP), which after 6 weeks of administration in the diet increases CoQ amount in the liver by five times (Fig. 11).

    View all citing articles on Scopus
    View full text